Michelle Waweru
Business Reporter and Writer at The Kenya Times
Business reporter and writer https://t.co/MLqvKlJg73 Muckrack: https://t.co/YGE5sZgKGA I write stories Reke ngwire
Articles
-
1 week ago |
startup-weekly.com | Michelle Waweru
Published: 20-06-2025 12:58:00 | By: Michelle Waweru | hits: 30 | Tags: Superlab Suisse announced the opening of its fourth Swiss laboratory facility at Campus Biotech in Geneva, which will be ready for move-in by January 2026. The new location will offer fully serviced laboratory space for biotech startups and life science companies in the Lake Geneva region.
-
1 week ago |
startup-weekly.com | Michelle Waweru
Published: 20-06-2025 12:58:00 | By: Michelle Waweru | hits: 147 | Tags: Biotech startup Superlab Suisse, has announced the opening of its fourth Swiss laboratory facility at Campus Biotech in Geneva, which will be ready for move-in by January 2026. The new location will offer fully serviced laboratory space for biotech startups and life science companies in the Lake Geneva region.
-
1 week ago |
africabusinesscommunities.com | Michelle Waweru
Kenya’s drive toward a clean energy future received a major boost this week as the state-owned Kenya Electricity Generating Company (KenGen) announced the arrival of critical equipment for its newest geothermal power plant at the Olkaria geothermal complex.
-
1 week ago |
africabusinesscommunities.com | Michelle Waweru
The European Bank for Reconstruction and Development (EBRD) and Morocco’s Office National de l’Electricité et de l’Eau potable (ONEE) have signed a €300 million loan agreement. ONEE is involved in generation, transmission and renewables. Morocco is strongly committed to the energy transition in order to achieve its objective of having 52 per cent of its installed capacity from renewables by 2030.
-
1 week ago |
africabusinesscommunities.com | Michelle Waweru
BioDlink announced that its self-developed Bevacizumab Injection (Pusintin®) has received marketing approval from National Agency for Food and Drug Administration and Control (NAFDAC) of Nigeria. This significant milestone accelerates BioDlink's global expansion efforts, and reaffirms its R&D and commercialization strength in biosimilar—offering a high-value, accessible treatment option for cancer patients worldwide.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 68
- Tweets
- 1K
- DMs Open
- Yes
RT @WanjikuReports: Protesters at AAR Hospital on Kiambu Road heading to the State House. #RutoMustGo #SiriNiNumbers https://t.co/Sh5E79R1CI
RT @theMagunga: No amount of teargas will turn us blind to injustice. Tupeni zingine! #SiriNiNumbers
RT @_Kitua_: Wenye mko home. YOU'RE THE MEDIA. RT and share every post. #SiriNiNumbers